JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged)

WKN A2PR31 | ISIN LU2053353749 |  Fonds
Factsheet
05.07.24
89,71 CHF-0,32 % (-0,29)
Name Aktuell Zeit Vortag Diff. % Diff. Vol. Stk.
Fonds 89,71 CHF 05.07.24 90,00 -0,32 % -0,29 -